The New Generation of Antibody Therapeutics: Current Status and Future
Prospects - Overview
Antibody sales are predicted to reach $50 billion this year.
This Insight Pharma Report
focuses on recent developments in the therapeutic antibody field and new...
More
The New Generation of Antibody Therapeutics: Current Status and Future
Prospects - Overview
Antibody sales are predicted to reach $50 billion this year.
This Insight Pharma Report
focuses on recent developments in the therapeutic antibody field and new technologies built
on the foundations of previously successful and unsuccessful strategies.
Following a review of the business environment and market forces, this report examines:
The state of the art, and the needs and direction, of antibody technology today
Antibody conjugates and other payloads: construction, clinical development, and corporate
activity
Multispecific and multifunctional antibodies: construction, clinical development, and
corporate activity
Development of biosimilars and biobetters: commercial and regulatory issues
Advances in product development technologies and overcoming biomanufacturing
challenges
IP challenges, deal structures, mergers and acquisitions
Marketed and clinical pipeline products, current status and
Less
